Corcept Therapeutics Incorporated shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $10M | 201k | 50.39 |
| 2024-09-30 | $9.4M | 203k | 46.28 |
| 2024-06-30 | $6.6M | 203k | 32.49 |
| 2024-03-31 | $5.2M | 207k | 25.19 |
| 2023-12-31 | $6.9M | 212k | 32.48 |
| 2023-09-30 | $5.6M | 205k | 27.24 |
| 2023-06-30 | $4.6M | 205k | 22.25 |
| 2023-03-31 | $4.6M | 211k | 21.66 |
| 2022-12-31 | $4.0M | 198k | 20.31 |
| 2022-09-30 | $5.0M | 197k | 25.64 |
| 2022-06-30 | $4.4M | 187k | 23.78 |
| 2022-03-31 | $4.1M | 182k | 22.52 |
| 2021-12-31 | $3.5M | 179k | 19.80 |
| 2021-09-30 | $3.5M | 180k | 19.68 |
| 2021-06-30 | $4.8M | 220k | 22.00 |
| 2021-03-31 | $5.3M | 223k | 23.79 |
| 2020-12-31 | $5.7M | 218k | 26.16 |
| 2020-09-30 | $3.8M | 218k | 17.41 |
| 2020-06-30 | $4.0M | 240k | 16.82 |
| 2020-03-31 | $3.0M | 254k | 11.89 |
| 2019-12-31 | $3.0M | 252k | 12.10 |
| 2019-09-30 | $3.3M | 233k | 14.13 |
| 2019-06-30 | $2.6M | 233k | 11.15 |
| 2019-03-31 | $2.7M | 228k | 11.74 |
| 2018-12-31 | $3.1M | 231k | 13.36 |
| 2018-09-30 | $2.6M | 184k | 14.02 |
| 2018-06-30 | $2.9M | 183k | 15.72 |
| 2018-03-31 | $2.8M | 172k | 16.45 |
| 2017-12-31 | $3.0M | 168k | 18.06 |
| 2017-09-30 | $1.7M | 89k | 19.30 |
| 2017-06-30 | $1.0M | 88k | 11.81 |
| 2017-03-31 | $791k | 72k | 10.96 |
| 2016-12-31 | $506k | 70k | 7.26 |
| 2016-09-30 | $390k | 60k | 6.50 |
| 2016-06-30 | $310k | 57k | 5.45 |
| 2016-03-31 | $227k | 49k | 4.67 |
| 2015-12-31 | $242k | 49k | 4.98 |
| 2015-09-30 | $165k | 44k | 3.77 |
| 2015-06-30 | $251k | 42k | 6.00 |
| 2015-03-31 | $243k | 44k | 5.59 |
| 2014-12-31 | $100k | 33k | 3.00 |
| 2014-09-30 | $112k | 42k | 2.67 |
| 2014-06-30 | $117k | 42k | 2.79 |
| 2014-03-31 | $190k | 44k | 4.37 |
| 2013-12-31 | $148k | 46k | 3.21 |
| 2013-09-30 | $74k | 46k | 1.60 |
| 2013-06-30 | $81k | 47k | 1.73 |
| 2013-03-31 | $79k | 39k | 2.01 |
| 2012-12-31 | $57k | 40k | 1.44 |
| 2012-09-30 | $119k | 43k | 2.79 |
| 2012-06-30 | $166k | 37k | 4.49 |
| 2012-03-31 | $132k | 34k | 3.93 |
| 2011-12-31 | $112k | 33k | 3.42 |
| 2011-09-30 | $153k | 49k | 3.11 |
| 2011-06-30 | $198k | 50k | 3.98 |
| 2011-03-31 | $161k | 38k | 4.26 |
| 2010-12-31 | $143k | 37k | 3.86 |
| 2010-09-30 | $125k | 32k | 3.90 |
| 2010-06-30 | $108k | 35k | 3.11 |
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated